Varicella Zoster Virus IE62 Antibodies

Santa Cruz Biotechnology offers a broad range of Varicella Zoster Virus IE62 monoclonal antibodies for research in virology and immunology. Varicella Zoster Virus IE62 Antibodies targeting IE62 are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The IE62 protein of the Varicella Zoster Virus plays a crucial role in viral replication and pathogenesis, acting as a transcriptional activator that enhances the expression of other viral genes. Understanding Varicella Zoster Virus IE62 protein function is essential for developing therapeutic strategies against infections and related diseases, such as shingles. Researchers can explore viral protein localization during different stages of infection using various detection methods. Advanced imaging techniques combined with IE62 monoclonal antibodies enable detailed visualization of protein distribution within infected cells. Comprehensive analysis of IE62 interactions with cellular factors helps reveal key aspects of viral pathogenesis. Santa Cruz Biotechnology monoclonal antibodies targeting Varicella Zoster Virus IE62 support scientific advancement in antiviral research and vaccine development.